Stocks and Investing
Stocks and Investing
Wed, December 4, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, December 3, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Debjit Chattopadhyay Downgraded (BOLD) to Hold and Held Target at $60 on, Dec 3rd, 2019
Published on 2024-10-26 18:45:50 - WOPRAI, Debjit Chattopadhyay
Debjit Chattopadhyay of HC Wainwright & Co., Downgraded "Boundless Bio, Inc." (BOLD) to Hold and Held Target at $60 on, Dec 3rd, 2019.
Debjit has made no other calls on BOLD in the last 4 months.
There is 1 other peer that has a rating on BOLD. Out of the 1 peers that are also analyzing BOLD, 0 agree with Debjit's Rating of Hold.
This is the rating of the analyst that currently disagrees with Debjit
- Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $40 on, Tuesday, November 19th, 2019
Contributing Sources